Connor, Clark & Lunn Investment Management (CC&L)’s Aura Biosciences AURA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-18,364
| Closed | -$151K | – | 1399 |
|
|
2024
Q4 | $151K | Sell |
18,364
-28,987
| -61% | -$238K | ﹤0.01% | 1347 |
|
|
2024
Q3 | $422K | Sell |
47,351
-11,704
| -20% | -$104K | ﹤0.01% | 1141 |
|
|
2024
Q2 | $446K | Sell |
59,055
-12,631
| -18% | -$95.5K | ﹤0.01% | 1081 |
|
|
2024
Q1 | $563K | Buy |
71,686
+58,764
| +455% | +$461K | ﹤0.01% | 1070 |
|
|
2023
Q4 | $114K | Buy |
+12,922
| New | +$114K | ﹤0.01% | 1310 |
|